Moderna Stock No-Brainer After FDA Win: Buy or Not?
A recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
Weekend jobs are perfect for those looking to boost their income. Discover opportunities that fit into your weekend routine.
16,346 articlesA recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
XBTFX announced the MCP Server and Skills Hub on July 1, 2026, creating a bridge between automated software and live ...
A little-known small-cap ETF is turning heads with bold gains in 2026. This guide explains what’s driving the perform...
A Scattered Spider suspect extradited to the US shines a light on how cross-border cybercrime prosecutions unfold. Th...
A surge in AI workloads hinges on memory, and Micron’s latest signals hint at lasting strength. This piece unpacks wh...
Korean equities ended a choppy week higher after reports that Anthropic and Samsung were in talks. The move capped a ...
A sharp, fear-driven decline hit Microsoft, but a deeper look suggests the selloff may reflect sentiment more than so...
As market dynamics shift in 2026, investors weigh broad market exposure against a tech-heavy Nasdaq-100 tilt. This re...
Mark Zuckerberg showcased a bold use of wearable tech by taking a business call from a jet ski, underscoring Meta's p...
Tightening UK election funding rules are set to change how crypto wealth can fund political campaigns. This could alt...
XRP is testing a critical price level in 2026 as regulatory clarity improves and ETF access expands. Analysts debate ...
As both ServiceNow and UiPath trade at appealing valuations, investors face a key question: should servicenow stock i...